BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Gaser, Christian ^a   Franke, Katja ^a   Klöppel, Stefan ^b   Koutsouleris, Nikolaos ^c   Sauer, Heinrich ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; BRAINAGE SCORE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HIPPOCAMPUS; HUMAN; KERNEL METHOD; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MONITORING; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PROBABILITY; RISK FACTOR; SCREENING; ATROPHY; BRAIN; COGNITIVE DEFECT; DEMENTIA; MIDDLE AGED; PATHOLOGY; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; ATROPHY; BIOMARKERS; BRAIN; COGNITIVE DYSFUNCTION; DEMENTIA; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 84879516484     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067346     Document Type: Article

References (73)

1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM, (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3: 186-191.
2. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, et al. (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9: 119-128.
3. Cao K, Chen-Plotkin AS, Plotkin JB, Wang LS, (2010) Age-correlated gene expression in normal and neurodegenerative human brain tissues. PLoS One 5: e13098.
4. Saetre P, Jazin E, Emilsson L, (2011) Age-related changes in gene expression are accelerated in Alzheimer's disease. Synapse 65: 971-974.
5. Jones DT, Machulda MM, Vemuri P, McDade EM, Zeng G, et al. (2011) Age-related changes in the default mode network are more advanced in Alzheimer disease. Neurology 77: 1524-1531.
6. Driscoll I, Davatzikos C, An Y, Wu X, Shen D, et al. (2009) Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology 72: 1906-1913.
7. Spulber G, Niskanen E, MacDonald S, Smilovici O, Chen K, et al. (2010) Whole brain atrophy rate predicts progression from MCI to Alzheimer's disease. Neurobiology of Aging 31: 1601-1605.
8. Dukart J, Schroeter ML, Mueller K, (2011) Age correction in dementia-matching to a healthy brain. PLoS One 6: e22193.
9. Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, et al. (2003) Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol 60: 1696-1702.
10. Strozyk D, Blennow K, White LR, Launer LJ, (2003) CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 60: 652-656.
11. Josephs KA, Whitwell JL, Ahmed Z, Shiung MM, Weigand SD, et al. (2008) Beta-amyloid burden is not associated with rates of brain atrophy. Ann Neurol 63: 204-212.
12. Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, et al. (2012) Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch Gen Psychiatry 69: 98-106.
13. Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, et al. (2009) Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 132: 1355-1365.
14. Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, et al. (2008) Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 65: 1509-1517.
15. Peskind ER, Li G, Shofer J, Quinn JF, Kaye JA, et al. (2006) Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition. Arch Neurol 63: 936-939.
16. Price JL, McKeel DW Jr, Buckles VD, Roe CM, Xiong C, et al. (2009) Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 30: 1026-1036.
17. Price JL, Morris JC, (1999) Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 45: 358-368.
18. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, et al. (2009) Age, neuropathology, and dementia. N Engl J Med 360: 2302-2309.
19. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, et al. (2009) Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 65: 403-413.
20. Hesse C, Rosengren L, Andreasen N, Davidsson P, Vanderstichele H, et al. (2001) Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci Lett 297: 187-190.
21. Schoonenboom NS, Reesink FE, Verwey NA, Kester MI, Teunissen CE, et al. (2012) Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology 78: 47-54.
22. Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, et al. (2009) MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology 73: 287-293.
23. Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, et al. (2009) MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology 73: 294-301.
24. Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM, (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6: 67-77.
25. Franke K, Ziegler G, Klöppel S, Gaser C, the Alzheimer's Disease Neuroimaging Initiative, (2010) Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods: Exploring the influence of various parameters. NeuroImage 50: 883-892.
26. Franke K, Luders E, May A, Wilke M, Gaser C, (2012) Brain maturation: Predicting individual BrainAGE in children and adolescents using structural MRI. NeuroImage 63: 1305-1312.
27. Franke K, Gaser C, for the Alzheimer's Disease Neuroimaging Initiative, (2012) Longitudinal changes in individual BrainAGE in healthy aging, mild cognitive impairment, and Alzheimer's disease. GeroPsych: The Journal of Gerontopsychology and Geriatric Psychiatry 25: 235-245.
28. Ashburner J, Friston KJ, (2005) Unified segmentation. NeuroImage 26: 839-851.
29. Tohka J, Zijdenbos A, Evans A, (2004) Fast and robust parameter estimation for statistical partial volume models in brain MRI. NeuroImage 23: 84-97.
30. Rajapakse JC, Giedd JN, Rapoport JL, (1997) Statistical approach to segmentation of single-channel cerebral MR images. IEEE Transactions on Medical Imaging 16: 176-186.
31. Cuadra MB, Cammoun L, Butz T, Cuisenaire O, Thiran JP, (2005) Comparison and validation of tissue modelization and statistical classification methods in T1-weighted MR brain images. IEEE Transactions on Medical Imaging 24: 1548-1565.
32. Gaser C, (2009) Partial volume segmentation with Adaptive Maximum a Posteriori (MAP) approach. NeuroImage 47: S121.
33. Tipping M (2000) The Relevance Vector Machine. In: Solla SA, Leen TK, Müller K-R, editors. Advances in Neural Information Processing Systems 12. Cambridge, MA: MIT Press. 652-658.
34. Bennett KP, Campbell C, (2003) Support vector machines: hype or hallelujah? SIGKDD Explorations 2: 1-13.
35. Schölkopf B, Smola A (2002) Learning with Kernels: Support Vector Machines, Regularization, Optimization, and Beyond. Cambridge, MA: MIT Press.
36. Ghosh S, Mujumdar PP, (2008) Statistical downscaling of GCM simulations to streamflow using relevance vector machine. Advances in Water Resources 31: 132-146.
37. Zheng Y-T, Neo S-Y, Chua T-S, Tian Q (2008) Probabilistic optimized ranking for multimedia semantic concept detection via RVM. Proceedings of the 2008 international conference on Content-based image and video retrieval. Niagara Falls, Canada: ACM. pp. 161-168.
38. Faul A, Tipping ME (2002) Analysis of sparse Bayesian learning. In: Dietterich TG, Becker S, Ghahramani Z, editors. Advances in Neural Information Processing Systems 14: MIT Press. pp. 383-389.
39. Tipping ME, Faul AC (2003) Fast marginal likelihood maximisation for sparse Bayesian models. In: Bishop CM, Frey BJ, editors; Jan 3-6; Key West, FL.
40. Bishop CM (2006) Pattern Recognition and Machine Learning. New York, NY: Springer.
41. Tipping ME, (2001) Sparse bayesian learning and the relevance vector machine. Journal of Machine Learning Research 1: 211-244.
42. Wilson RS, Leurgans SE, Boyle PA, Bennett DA, (2011) Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Archives of Neurology 68: 351-356.
43. Desikan RS, Fischl B, Cabral HJ, Kemper TL, Guttmann CR, et al. (2008) MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD. Neurology 71: 819-825.
44. Duchesne S, Caroli A, Geroldi C, Collins DL, Frisoni GB, (2009) Relating one-year cognitive change in mild cognitive impairment to baseline MRI features. Neuroimage 47: 1363-1370.
45. Stonnington CM, Chu C, Klöppel S, Jack CR, Ashburner J, et al. (2010) Predicting clinical scores from magnetic resonance scans in Alzheimer's disease. Neuroimage 51: 1405-1413.
46. Wang Y, Fan Y, Bhatt P, Davatzikos C, (2010) High-dimensional pattern regression using machine learning: from medical images to continuous clinical variables. Neuroimage 50: 1519-1535.
47. Clark VH, Resnick SM, Doshi J, Beason-Held LL, Zhou Y, et al. (2012) Longitudinal imaging pattern analysis (SPARE-CD index) detects early structural and functional changes before cognitive decline in healthy older adults. Neurobiology of Aging 33: 2733-2745.
48. Hinrichs C, Singh V, Xu G, Johnson SC, (2011) Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population. Neuroimage 55: 574-589.
49. Walhovd KB, Fjell AM, Brewer J, McEvoy LK, Fennema-Notestine C, et al. (2010) Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease. AJNR Am J Neuroradiol 31: 347-354.
50. Zhang D, Wang Y, Zhou L, Yuan H, Shen D, (2011) Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage 55: 856-867.
51. Misra C, Fan Y, Davatzikos C, (2009) Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage 44: 1415-1422.
52. Querbes O, Aubry F, Pariente J, Lotterie JA, Demonet JF, et al. (2009) Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. Brain 132: 2036-2047.
53. Teipel SJ, Born C, Ewers M, Bokde AL, Reiser MF, et al. (2007) Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment. Neuroimage 38: 13-24.
54. Westman E, Simmons A, Zhang Y, Muehlboeck JS, Tunnard C, et al. (2011) Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls. Neuroimage 54: 1178-1187.
55. Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, Trojanowski JQ, (2011) Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol Aging 32: 2322.e2319-2322.e2327.
56. Westman E, Muehlboeck J-S, Simmons A, (2012) Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion. Neuroimage 62: 229-238.
57. Wolz R, Julkunen V, Koikkalainen J, Niskanen E, Zhang DP, et al. (2011) Multi-Method Analysis of MRI Images in Early Diagnostics of Alzheimer's Disease. Plos ONE 6: e25446.
58. Fan Y, Batmanghelich N, Clark CM, Davatzikos C, (2008) Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. Neuroimage 39: 1731-1743.
59. Costafreda SG, Dinov ID, Tu Z, Shi Y, Liu CY, et al. (2011) Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuroimage 56: 212-219.
60. Risacher SL, Saykin AJ, West JD, Shen L, Firpi HA, et al. (2009) Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res 6: 347-361.
61. Risacher SL, Shen L, West JD, Kim S, McDonald BC, et al. (2010) Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol Aging 31: 1401-1418.
62. Klöppel S, Abdulkadir A, Hadjidemetriou S, Issleib S, Frings L, et al. (2011) A comparison of different automated methods for the detection of white matter lesions in MRI data. Neuroimage 57: 416-422.
63. Nelson PT, Head E, Schmitt FA, Davis PR, Neltner JH, et al. (2011) Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies. Acta Neuropathol 121: 571-587.
64. Ohnishi T, Matsuda H, Tabira T, Asada T, Uno M, (2001) Changes in brain morphology in Alzheimer disease and normal aging: is Alzheimer disease an exaggerated aging process? AJNR Am J Neuroradiol 22: 1680-1685.
65. Chen JH, Lin KP, Chen YC, (2009) Risk factors for dementia. Journal of the Formosan Medical Association 108: 754-764.
66. Fotenos AF, Mintun MA, Snyder AZ, Morris JC, Buckner RL, (2008) Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve. Arch Neurol 65: 113-120.
67. Snowdon DA, (2003) Healthy aging and dementia: findings from the Nun Study. Ann Intern Med 139: 450-454.
68. Mangialasche F, Westman E, Kivipelto M, Muehlboeck JS, Cecchetti R, et al. (2013) Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of alpha-/gamma-tocotrienols and gamma-tocopherol. Journal of internal medicine.
69. Deary IJ, Whiteman MC, Pattie A, Starr JM, Hayward C, et al. (2002) Cognitive change and the APOE epsilon 4 allele. Nature 418: 932.
70. Cosentino S, Scarmeas N, Helzner E, Glymour MM, Brandt J, et al. (2008) APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology 70: 1842-1849.
71. Wishart HA, Saykin AJ, Rabin LA, Santulli RB, Flashman LA, et al. (2006) Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele. Am J Psychiatry 163: 1603-1610.
72. Filippini N, Rao A, Wetten S, Gibson RA, Borrie M, et al. (2009) Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease. Neuroimage 44: 724-728.
73. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, et al. (2000) Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 343: 450-456.